Please note that this website is not meant for consumers, as the information contained herein does not refer to finished products.
This website is available in various countries all over the world. As such, it may contain statements that are not applicable to your region.
PLANT
Duboisia
PART OF THE PLANT USED
Leaves
APPEARANCE
White or almost white Crystalline powder
CAS NUMBER
149-64-4
A peripherally-acting antimuscarinic and anticholinergic agent, Linnea has produced pharmaceutical grade Butylscopolamine in its manufacturing facilities since 1985, obtaining this semi-synthetic derivative from the leaves of the Duboisia plant.
• Smooth muscles spasms
• Renal colic pain
• Dysmenorrhea
• Irritable bowel syndrome
Non-sterile suitable for injectable pharmaceutical forms
Complies with Ph. Eur. “Hyoscine butylbromide” monograph, current edition
CEP
Ph. Eur.
DMF
GMP compliant by Swissmedic
GACP compliant
We are proud to be vertically integrated in our supply chain for this important beneficial ingredient. Linnea has been manufacturing Butylscopolamine since 1985 in our GMP certified facility. We manage our own supply chain and have full traceability for this important ingredient.
